Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile

Docetaxel is a highly potent anticancer agent being used in a wide spectrum of cancer types. There are important matters of concern regarding the drug’s pharmacokinetics related to the conventional formulation. Poly(lactide-co-glycolide) (PLGA) is a biocompatible/biodegradable polymer with variable physicochemical characteristics, and its application in human has been approved by the United States Food and Drug Administration. PLGA gives polymeric nanoparticles with unique drug delivery characteristics. The application of PLGA nanoparticles (NPs) as intravenous (IV) sustained-release delivery vehicles for docetaxel can favorably modify pharmacokinetics, biofate, and pharmacotherapy of the drug in cancer patients. Surface modification of PLGA NPs with poly(ethylene glycol) (PEG) can further enhance NPs’ long-circulating properties. Herein, an optimized fabrication approach has been used for the preparation of PLGA and PLGA–PEG NPs loaded with docetaxel for IV application. Both types of NP formulations demonstrated in vitro characteristics that were considered suitable for IV administration (with long-circulating sustained-release purposes). NP formulations were IV administered to an animal model, and docetaxel’s pharmacokinetic and biodistribution profiles were determined and compared between study groups. PLGA and PEGylated PLGA NPs were able to modify the pharmacokinetics and biodistribution of docetaxel. Accordingly, the mode of changes made to pharmacokinetics and biodistribution of docetaxel is attributed to the size and surface properties of NPs. NPs contributed to increased blood residence time of docetaxel fulfilling their role as long-circulating sustained-release drug delivery systems. Surface modification of NPs contributed to more pronounced docetaxel blood concentration, which confirms the role of PEG in conferring long-circulation properties to NPs.

• Publication year

  2017

• Venue

  International Journal of Nanomedicine

• Publication date

  2017-01-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2147/IJN.S121881PMID 28184163PMCID 5291330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular distribution of injected PLGA-nanoparticles in the liver.

  2016cited by this paper
• Biodegradable Nanoparticles and Their In Vivo Fate

  2016cited by this paper
• Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.

  2016cited by this paper
• Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.

  2015cited by this paper
• Application of a Rapid ESI-MS/MS Method for Quantitative Analysis of Docetaxel in Polymeric Matrices of PLGA and PLGA-PEG Nanoparticles through Direct Injection to Mass Spectrometer

  2015cited by this paper
• Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome.

  2015cited by this paper
• Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.

  2014cited by this paper
• A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.

  2013cited by this paper
• Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

  2013cited by this paper
• Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.

  2013cited by this paper
• Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique

  2013cited by this paper
• Docetaxel Nanotechnology in Anticancer Therapy

  2012cited by this paper
• Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective.

  2012cited by this paper
• Nanotechnology-based approaches in anticancer research

  2012cited by this paper
• Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies

  2011influential reference
• Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

  2011cited by this paper
• Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid

  2011cited by this paper
• Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

  2011cited by this paper
• HER-2 targeted immunonanoparticles for breast cancer chemotherapy

  2011influential reference
• Nanomedicine in cancer therapy: Innovative trends and prospects

  2011cited by this paper
• Mechanical modulation of cardiac microtubules

  2011cited by this paper
• The effects of particle size, density and shape on margination of nanoparticles in microcirculation

  2011cited by this paper
• Nanotherapeutics to overcome conventional cancer chemotherapy limitations.

  2011cited by this paper
• Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles

  2010cited by this paper
• Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

  2010cited by this paper
• Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles.

  2010cited by this paper
• Nanoparticles for tumor targeted therapies and their pharmacokinetics.

  2010cited by this paper
• Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

  2010cited by this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cited by this paper
• Cytotoxicity of Paclitaxel Incorporated in PLGA Nanoparticles on Hypoxic Human Tumor Cells

  2009cited by this paper
• Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.

  2008influential reference
• Nanoparticles for drug delivery in cancer treatment.

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Shedding light on tumors using nanoparticles.

  2008cited by this paper
• The role of microtubules in cell biology, neurobiology, and oncology /

  2008cited by this paper
• Therapeutic Nanoparticles for Drug Delivery in Cancer

  2008cited by this paper
• Preparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion method

  2008cited by this paper
• Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics.

  2007cited by this paper
• Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.

  2007cited by this paper
• Chapter 2 – Mouse Physiology

  2007cited by this paper
• Clinical Pharmacokinetics of Docetaxel

  2006cited by this paper
• Synthesis and characterization of PLGA nanoparticles

  2006cited by this paper
• Preparation of poly(lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution

  2006cited by this paper
• Pharmacokinetic Consequences of Pegylation

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• PLA/PLGA nanoparticles for sustained release of docetaxel.

  2006cited by this paper
• Anticancer drug delivery with nanoparticles.

  2006cited by this paper
• Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity.

  2005influential reference
• Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins

  2003cited by this paper
• Pharmacological Effects of Formulation Vehicles

  2003cited by this paper
• A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.

  2003cited by this paper
• Mode of action of docetaxel - a basis for combination with novel anticancer agents.

  2003cited by this paper
• Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles.

  2003cited by this paper
• Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases

  2003cited by this paper
• Quantitation and Distribution of β-tubulin in Human Cardiac Myocytes

  2002cited by this paper
• Paclitaxel and its formulations.

  2002cited by this paper
• Quantitation and distribution of beta-tubulin in human cardiac myocytes.

  2002cited by this paper
• Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytesin Vitro and in Vivo *

  2001cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Role of Formulation Vehicles in Taxane Pharmacology

  2001cited by this paper
• Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density

  2001cited by this paper
• Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption.

  2000cited by this paper
• Taxanes: an overview of the pharmacokinetics and pharmacodynamics.

  1999cited by this paper
• Clinical Pharmacokinetics of Docetaxel

  1999cited by this paper
• Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.

  1999cited by this paper
• Preclinical pharmacokinetics of paclitaxel and docetaxel.

  1998cited by this paper
• Contact allergenic activity of Tween® 80 before and after air exposure

  1997cited by this paper
• The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

  1995cited by this paper
• 16 Microtubule Stabilizing Agents in Clinical Oncology The Taxanes

  year unknowncited by this paper
• International Journal of Nanomedicine

  year unknowncited by this paper
• Docetaxel-loaded Plga and Plga-Peg nanoparticles for intravenous application: pharmacokinetics and biodistribution profile

  year unknowncited by this paper

• Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy.

  2026cites this paper
• How do nanoparticle properties shape pharmacokinetics and pharmacodynamics? A mechanistic review.

  2026cites this paper
• Anti‐PSMA Functionalized PLGA‐PEG Nanoparticles for Active Targeting of LnCap Cells and Controlled Release of Docetaxel in Prostate Cancer

  2025influential citation
• Development and Optimisation of Docetaxel-Loaded Polymeric Nanoparticles for Oral Chemotherapy in Breast Cancer

  2025cites this paper
• Dual-membrane bioinspired nanocarriers for targeted therapy of MRSA-induced acute lung injury and bacteremia.

  2025cites this paper
• Folate-Functionalized Polymeric Nanoparticles for 5‑Fluorouracil Delivery to Prostate Cancer: Physicochemical and In Vitro/In Vivo Characterization

  2025cites this paper
• A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease

  2025cites this paper
• Mannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis

  2025cites this paper
• Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver.

  2025cites this paper
• Enhanced in vitro anticancer activity of liposome-encapsulated nanocordycepin in breast and cervical cancer cells

  2025cites this paper
• Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models.

  2025cites this paper
• Biodegradable microrollers for magnetic drug targeting.

  2025cites this paper
• PLGA/TPGS nanoparticles for docetaxel delivery: the pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells.

  2025cites this paper
• Recent advances in extracellular matrix-inspired nanocarriers

  2025cites this paper
• Development and statistical optimization of camptothecin loaded hyaluronic acid and zein polymeric nanoparticles towards the treatment of melanoma.

  2025cites this paper
• Blood nerve barrier permeability enables nerve targeting of circulating nanoparticles in experimental autoimmune neuritis

  2025cites this paper
• Research Progress of Docetaxel Nano-Drug Delivery System in the Treatment of Breast Cancer

  2025cites this paper
• Development of Polymeric Nanoparticles Loaded with Phlomis crinita Extract: A Promising Approach for Enhanced Wound Healing

  2025cites this paper
• AD1 Aptamer-Engineered Fluconazole-Loaded PLGA-PEG Nanoformulations Potentiate Antifungal Efficacy through Biofilm-Penetrating Targeting against Candida albicans.

  2025cites this paper
• Development and Evaluation of Tumor-Targeting Curcumin-Loaded Magnetic Nanoparticles Based on PEG-PLGA and Transferrin for Anti-Lung Cancer Therapy

  2025cites this paper
• Water-soluble fluorinated copolymers as highly sensitive 19F MRI tracers: From structure optimization to multimodal tumor imaging

  2025cites this paper
• Polysaccharide copolymeric conjugates and their applications in targeted cancer therapy.

  2025cites this paper
• Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups

  2025cites this paper
• Enhanced Nanoprecipitation Method for the Production of PLGA Nanoparticles for Oncology Applications

  2025cites this paper
• A Recent Review of PLGA-PEG Hybrid Nanoparticles for Anticancer and Anti-Inflammatory Applications

  2025cites this paper
• Biodegradable PLGA Particles with Confined Water for Safe Photothermal Biomodulation.

  2025cites this paper
• Nanoparticle Association with Brain Cells Is Augmented by Protein Coronas Formed in Cerebrospinal Fluid.

  2025cites this paper
• Effects of combined CBGA and cannabis-derived terpene nanoformulations on TRPV1 activation: Implications for enhanced pain management.

  2025cites this paper
• A Sustained-Release SP-Sr-CaS/NBD Microsphere for Promoting Bone Repair and Inhibiting Inflammation for the Treatment of Osteomyelitis

  2024cites this paper
• Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Antitumor Immunity and Eliminates Tumors.

  2024cites this paper
• AICAR-loaded and panitumumab conjugated nanoparticles downregulate the expression of PD-L1 and enhance antitumor responses against ovarian cancer through the AMPK/STAT3 axis

  2024cites this paper
• PLGA nanoparticles for nasal drug delivery

  2024cites this paper
• Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis.

  2024cites this paper
• Ameliorative Delivery of Docetaxel and Curcumin using PEG Decorated Lipomers: A Cutting-Edge In-Vitro/ In-Vivo Appraisal

  2024cites this paper
• Quantitative Label-Free Chemical Imaging of PLGA Nanoparticles in Cells and Tissues with Single-Particle Sensitivity.

  2024cites this paper
• The effects of ligand distribution and density on the targeting properties of dual-targeting folate/biotin Pluronic F127/Poly (lactic acid) polymersomes.

  2024cites this paper
• Selective imaging, gene, and therapeutic delivery using PEGylated and pH-Sensitive nanoparticles for enhanced lung disorder treatment.

  2024cites this paper
• Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment.

  2024cites this paper
• Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry

  2024cites this paper
• The influence of various polymer coatings on the in vitro and in vivo properties of PLGA nanoparticles: Comprehensive study.

  2024cites this paper
• Nano-enabled delivery of diosgenin and emodin ameliorates respirable silica dust-induced pulmonary fibrosis silicosis in rats.

  2024cites this paper
• In vitro evaluation and in situ intestinal absorption characterisation of paeoniflorin nanoparticles in a rat model

  2024cites this paper
• Surface modification of hollow gold nanoparticles conducted by incorporating cancer cell membrane and AS1411 aptamer, aiming to achieve a dual-targeted therapy for colorectal cancer.

  2024cites this paper
• Application of PLGA in Tumor Immunotherapy

  2024cites this paper
• pH-tailored delivery of a multitarget anticancer benzimidazole derivative using a PEGylated β-cyclodextrin-curcumin functionalized nanocomplex.

  2024cites this paper
• Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies

  2023cites this paper
• Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.

  2023cites this paper
• Boosting Glioblastoma Therapy with Targeted Pyroptosis Induction.

  2023cites this paper
• Neonatal Pharmacokinetics and Biodistribution of Polymeric Nanoparticles and Effect of Surfactant

  2023cites this paper
• Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug

  2023cites this paper
• Anti‐Biofilm Effect of Ampicillin‐Loaded Poly (Lactic‐co‐glycolic Acid) Nanoparticles Conjugated with Lysostaphin on Methicillin‐Resistant Staphylococcus aureus

  2023cites this paper
• Applications of nanomaterials in anti-VEGF treatment for ophthalmic diseases.

  2023cites this paper
• Docetaxel-Loaded Methoxy poly(ethylene glycol)-poly (L-lactic Acid) Nanoparticles for Breast Cancer: Synthesis, Characterization, Method Validation, and Cytotoxicity

  2023cites this paper
• Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function.

  2023cites this paper
• Dual-targeted transferrin and AS1411 aptamer conjugated micelles for improved therapeutic efficacy and imaging of brain cancer.

  2023cites this paper
• Nanoarchitectonics of versatile platform based on graphene oxide for precise and enhanced synergistic cancer photothermal-photodynamic/chemotherapy

  2023cites this paper
• Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages.

  2023cites this paper
• Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.

  2023cites this paper
• TH-302-loaded nanodrug reshapes the hypoxic tumour microenvironment and enhances PD-1 blockade efficacy in gastric cancer

  2023cites this paper
• The interactions of docetaxel with tumor microenvironment.

  2023cites this paper
• Evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment.

  2023cites this paper
• Nanomaterials in tumor immunotherapy: new strategies and challenges

  2023cites this paper
• Drug Delivery Approaches to Improve Tendon Healing

  2023cites this paper
• Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer

  2023cites this paper
• Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine

  2023cites this paper
• An overview of the material science and knowledge of nanomedicine, bioscaffolds, and tissue engineering for tendon restoration

  2023cites this paper
• Nanoformulation, Characterization, and In Vivo Pharmacokinetic Studies of Diosgenin- and Emodin-Loaded Polymeric Nanoparticles

  2023influential citation
• 3D in vitro hydrogel models to study the human lung extracellular matrix and fibroblast function

  2023cites this paper
• Integrating osteoimmunology and nanoparticle-based drug delivery systems for enhanced fracture healing.

  2023cites this paper
• Advancements in nanoparticle-based treatment approaches for skin cancer therapy

  2023influential citation
• Biomaterial-targeted precision nanoparticle delivery to the injured spinal cord.

  2022cites this paper
• PLGA-graphene quantum dot nanocomposites targeted against αvβ3 integrin receptor for sorafenib delivery in angiogenesis.

  2022cites this paper
• Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary Infections

  2022cites this paper
• Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer

  2022cites this paper
• POLYCAPROLACTONE NANOPARTICLES AS DELIVERY VEHICLE IN COMBATING DISEASES

  2022cites this paper
• Antimicrobial activity of the PEGylated antibiotic enrofloxacin and its functional and structural effect on the liver in rats

  2022cites this paper
• Boosting the Therapeutic Efficacy of Discoidal Nanoconstructs against Glioblastoma with Rationally Designed PEG-Docetaxel Conjugates.

  2022cites this paper
• A Nanoparticle’s Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations

  2022cites this paper
• Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer

  2022cites this paper
• Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

  2022influential citation
• Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against Fusarium Solani

  2022influential citation
• Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro

  2022cites this paper
• Fluorophore Localization Determines the Results of Biodistribution of Core-Shell Nanocarriers

  2022cites this paper
• Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer

  2022cites this paper
• Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.

  2022cites this paper
• Potential Use for Chronic Pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) Nanoparticles Enhance the Effects of Cannabis-Based Terpenes on Calcium Influx in TRPV1-Expressing Cells.

  2022cites this paper
• Effects of rAmb a 1-Loaded PLGA-PEG Nanoparticles in a Murine Model of Allergic Conjunctivitis

  2022cites this paper
• PLGA/PEG Nanoparticles Loaded with Cyclodextrin-Peganum harmala Alkaloid Complex and Ascorbic Acid with Promising Antimicrobial Activities

  2022cites this paper
• Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy

  2022cites this paper
• CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting

  2022cites this paper
• A novel docetaxel derivative exhibiting potent anti-tumor activity and high safety in preclinical animal models.

  2022cites this paper
• Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via the Ly6 antigen for psoriasiform dermatitis alleviation.

  2022cites this paper
• Preparation and Phytotoxicity Evaluation of Cellulose Acetate Nanoparticles

  2022cites this paper
• Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling

  2022cites this paper
• A review on nanoparticles targeting cervical and endometrial cancer

  2022cites this paper
• Nanomaterials: small particles show huge possibilities for cancer immunotherapy

  2022cites this paper
• Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review

  2022cites this paper
• Potential of Alpha-Mangostin-Loaded PLGA Nanoparticles for Cholangiocarcinoma Treatment

  2022cites this paper
• RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment

  2022cites this paper
• Targeting nanoparticle-conjugated microbubbles combined with ultrasound-mediated microbubble destruction for enhanced tumor therapy.

  2022cites this paper